In vivo tracking of tumor-specific T cells

Cassian Yee; Stanley R. Riddell; Philip D. Greenberg

doi:10.1016/S0952-7915(00)00196-5

In vivo tracking of tumor-specific T cells

Cassian Yee, Stanley R. Riddell, Philip D. Greenberg

Research output: Contribution to journal › Review article › peer-review

62 Scopus citations

Abstract

Novel immunologic assays now enable visualization of the antigen-specific response to an extent not previously possible. Assessment of not only the numeric frequency but also the functional properties of individual tumor-specific T cells in the endogenous and manipulated immune response has provided insights that will facilitate the development of immunotherapeutic strategies.

Original language	English (US)
Pages (from-to)	141-146
Number of pages	6
Journal	Current Opinion in Immunology
Volume	13
Issue number	2
DOIs	https://doi.org/10.1016/S0952-7915(00)00196-5
State	Published - Apr 1 2001
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/S0952-7915(00)00196-5

Cite this

@article{0185a04c9aaa4034bc6d6aa1abe568df,

title = "In vivo tracking of tumor-specific T cells",

abstract = "Novel immunologic assays now enable visualization of the antigen-specific response to an extent not previously possible. Assessment of not only the numeric frequency but also the functional properties of individual tumor-specific T cells in the endogenous and manipulated immune response has provided insights that will facilitate the development of immunotherapeutic strategies.",

author = "Cassian Yee and Riddell, {Stanley R.} and Greenberg, {Philip D.}",

note = "Funding Information: This work was supported by Cancer Research Institute (CY), Burroughs Wellcome Fund (CY) and National Institutes for Health (NIH)-CA 7149 (CY). ",

year = "2001",

month = apr,

day = "1",

doi = "10.1016/S0952-7915(00)00196-5",

language = "English (US)",

volume = "13",

pages = "141--146",

journal = "Current Opinion in Immunology",

issn = "0952-7915",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - In vivo tracking of tumor-specific T cells

AU - Yee, Cassian

AU - Riddell, Stanley R.

AU - Greenberg, Philip D.

N1 - Funding Information: This work was supported by Cancer Research Institute (CY), Burroughs Wellcome Fund (CY) and National Institutes for Health (NIH)-CA 7149 (CY).

PY - 2001/4/1

Y1 - 2001/4/1

N2 - Novel immunologic assays now enable visualization of the antigen-specific response to an extent not previously possible. Assessment of not only the numeric frequency but also the functional properties of individual tumor-specific T cells in the endogenous and manipulated immune response has provided insights that will facilitate the development of immunotherapeutic strategies.

AB - Novel immunologic assays now enable visualization of the antigen-specific response to an extent not previously possible. Assessment of not only the numeric frequency but also the functional properties of individual tumor-specific T cells in the endogenous and manipulated immune response has provided insights that will facilitate the development of immunotherapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=0035314005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035314005&partnerID=8YFLogxK

U2 - 10.1016/S0952-7915(00)00196-5

DO - 10.1016/S0952-7915(00)00196-5

M3 - Review article

C2 - 11228405

AN - SCOPUS:0035314005

SN - 0952-7915

VL - 13

SP - 141

EP - 146

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

IS - 2

ER -

In vivo tracking of tumor-specific T cells

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this